COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,582 Articles (22,415 medRxiv, 8,167 bioRxiv)

Most recent first Previous |  Page 1402: Articles 14011-14020  | Next

Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152
Yadav, P. D., Sapkal, G., Ella, R., Sahay, R. R., Nyayanit, D. A., Patil, D. Y., Deshpande, G., Shete, A. M., Gupta, N., Mohan, V. K., Abraham, P., Panda, S., Bhargava, B.
10.1101/2021.06.05.447177 — Posted: 2021-06-07 Discussion: Onsite | Offsite
A Web Portal and Workbench for Biological Dissection of Single Cell COVID-19 Host Responses
Jin, K., Bardes, E. E., Mitelpunkt, A., Wang, Y. J., Bhatnagar, S., Sengupta, S., Krummel, D. P., Rothenberg, M. E., Aronow, B. J.
10.1101/2021.06.07.447287 — Posted: 2021-06-07
Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study
Ge, J., Pletcher, M. J., Lai, J. C., N3C Consortium
10.1101/2021.06.03.21258312 — Posted: 2021-06-07
Long-COVID following mild SARS CoV-2 infection: characteristic T cell alterations and response to antihistamines
Glynne, P., Tahmasebi, N., Gant, V. A., Gupta, R.
10.1101/2021.06.06.21258272 — Posted: 2021-06-07
Revealing public opinion towards COVID-19 vaccines using Twitter data in the United States: a spatiotemporal perspective
Hu, T., Wang, S., Luo, W., Yan, Y., Zhang, M., Huang, X., Liu, R., Ly, K., Kacker, V., Li, Z.
10.1101/2021.06.02.21258233 — Posted: 2021-06-07
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant
Thorne, L. G., Bouhaddou, M., Reuschl, A.-K., Zuliani-Alvarez, L., Polacco, B. J., Pelin, A., Batra, J., Whelan, M. V. X., Ummadi, M., Roic, A., Turner, J., Obernier, K., Braberg, H., Soucheray, M., Richards, A. L., Chen, K.-H., Harjai, B., Memon, D., Hosmillo, M., Hiatt, J., Jahun, A. S., Goodfellow, I. G., Noursadeghi, M., Fabius, J., Shokat, K., Jura, N., Verba, K. A., Beltrao, P., Swaney, D. L., Garcia-Sastre, A., Jolly, C., Towers, G. J., Krogan, N. J.
10.1101/2021.06.06.446826 — Posted: 2021-06-07 Discussion: Onsite
Ambient air pollution and COVID-19 in National Capital Territory of Delhi, India: a time-series evidence
Singh, A.
10.1101/2021.06.04.21258376 — Posted: 2021-06-07
Effects of immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19
Alfano, G., Damiano, F., Fontana, F., Ferri, C., Giaroni, F., Melluso, A., Montani, M., Morisi, N., Plessi, J., Tei, L., Giovanella, S., Ligabue, G., Mori, G., Guaraldi, G., Magistroni, R., Cappelli, G.
10.1101/2021.06.06.21258414 — Posted: 2021-06-07
Self-reported adaptability among postgraduate dental learners and their instructors: accelerated change induced by COVID-19
Otaki, F., Amir-Rad, F., Al-Halabi, M., Baqain, Z., Zary, N.
10.1101/2021.06.05.21258401 — Posted: 2021-06-07
Immunogenicity of the ChAdOx1 nCoV-19 and the BBV152 Vaccines in Patients with Autoimmune Rheumatic Diseases
Shenoy, P., Ahmed, S., Cherin, S., Paul, A., Shenoy, V., Vijayan, A., Reji, R., Thampi, A., Babu AS, S., Mohan, M.
10.1101/2021.06.06.21258417 — Posted: 2021-06-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).